Home / News / Publications

Publications

Anti-retinal antibodies in patients with macular telangiectasia type 2.

Zhu L, Shen W, Zhu M, Coorey NJ, Nguyen AP, Barthelmes D, Gillies MC. Invest Ophthalmol Vis Sci. 2013 Aug 21;54(8):5675-83.

Staging of macular telangiectasia: power-Doppler optical coherence tomography and macular pigment optical density.

Chin EK, Kim DY, Hunter AA 3rd, Pilli S, Wilson M, Zawadzki RJ, Werner JS, Park SS. Invest Ophthalmol Vis Sci. 2013 Jul 2;54(7):4459-70.

Is indocyanine green angiography useful for the diagnosis of macular telangiectasia type 2?

Niskopoulou M, Balaskas K, Leung I, Sallo FB, Clemons TE, Bird AC, Peto T; MacTel Study group. Br J Ophthalmol. 2013 Jul;97(7):946-8.

Medical Characteristics of Patients with Macular Telangiectasia Type 2 (MacTel Type 2) MacTel Project Report No. 3.

Clemons TE, Gillies MC, Chew EY, Bird AC, Peto T, Wang JJ, Mitchell P, Ramdas WD, Vingerling JR, Macular Telangiectasia Project Research Group. Ophthalmic Epidemiology 2013; April 20(2):109-113.

Associations between autofluorescence abnormalities and visual acuity in idiopathic macular telangiectasia type 2: MacTel Project Report Number 5.

Balaskas K, Leung I, Sallo FB, Clemons TE, Bird AC, Peto T. Retina. 2014 Aug;34(8):1630-6.

Characteristics of cystoid spaces in type 2 idiopathic macular telangiectasia on spectral domain optical coherence tomography images.

Oh JH, Oh J, Togloom A, Kim SW, Huh K. Retina. 2014 Jun;34(6):1123-31.

Outcomes of macular hole surgeries for macular telangiectasia type 2.

Karth PA, Raja SC, Brown DM, Kim JE. Retina. 2014 May;34(5):907-15.

First symptoms and their age of onset in macular telangiectasia type 2

Heeren TF, Holz FG, Charbel Issa P. Retina. 2014 May;34(5):916-9.

Newer Publications